Bipolar Mania - Acute Management

Key Points

• Mania causes marked impairment, may include psychosis, and often requires hospitalization when safety or function is compromised.
• Obtain collateral history because insight and recall may be limited during an acute episode.
• Evaluate for substances, medications, thyroid disease, delirium, and neurologic causes, especially in first or late-life presentations.
• Stop destabilizing antidepressants or stimulants when clinically appropriate.
• Lithium, valproate, and several antipsychotics are evidence-based acute antimanic treatments.
• Severe mania often requires an antipsychotic plus a mood stabilizer and a structured inpatient environment.
• Valproate carries major pregnancy and reproductive risks and requires careful restriction and counseling.
• ECT is effective for severe, resistant, intolerant, or rapidly deteriorating mania.

Algorithm

1. Assess immediate safety, psychosis, agitation, suicidality, sleep, hydration, and ability to care for basic needs.
2. Obtain collateral history and review substances, antidepressants, stimulants, steroids, and medical causes.
3. Perform targeted baseline laboratory and medical evaluation before selecting medication.
4. Admit severe, dangerous, psychotic, or functionally incapacitating mania.
5. Stop likely destabilizing agents and restore sleep in a low-stimulation setting.
6. Start an evidence-based antimanic agent; combine antipsychotic and mood stabilizer in severe presentations when appropriate.
7. Consider ECT when rapid response is needed or medication is ineffective or poorly tolerated.
8. After remission, create a maintenance, relapse-prevention, substance-use, sleep, and monitoring plan.

Clinical Synopsis & Reasoning

Mania is a sustained syndrome of elevated, expansive, or markedly irritable mood accompanied by increased energy and symptoms such as decreased need for sleep, pressured speech, racing thoughts, grandiosity, distractibility, psychomotor activation, and high-risk behavior. Severity distinguishes mania from hypomania: mania causes marked functional impairment, may require hospitalization, or includes psychosis. Mixed features can combine manic energy with depressive symptoms and may carry substantial suicide risk.

Establish whether this is a known bipolar episode or a first presentation. Obtain collateral information because insight is commonly impaired. Ask about antidepressants, stimulants, corticosteroids, dopaminergic medications, sleep loss, substance use, and recent medication discontinuation. Medical mimics include hyperthyroidism, neurologic disease, infection, delirium, and medication or substance effects. New-onset mania in an older adult deserves especially careful medical and neurologic evaluation.

Assess danger to self or others, ability to care for basic needs, financial and sexual risk, driving, access to weapons, psychosis, agitation, and sleep deprivation. Severe emergent agitation must be managed immediately. A patient with dangerous behavior, psychosis, inability to sleep for days, inability to eat or drink, severe impulsivity, or lack of a safe environment generally requires hospitalization. Pregnancy potential matters because valproate and several other medications carry major reproductive risks.

Treatment Strategy & Disposition

Stop antidepressants or stimulants that may be contributing unless a compelling reason and specialist plan indicate otherwise. Restore sleep and reduce stimulation. Evidence-based acute antimanic options include lithium, valproate, and several second-generation antipsychotics. Choice depends on severity, previous response, renal and hepatic function, pregnancy potential, metabolic risk, drug interactions, and the need for rapid behavioral control. Antipsychotics often act faster than lithium for agitation and psychosis and can be combined with a mood stabilizer in severe mania.

Lithium is highly effective for classic mania and long-term suicide-risk reduction but requires renal and thyroid assessment, medication-interaction review, hydration stability, and serum-level monitoring. Valproate can be effective in acute mania but has major teratogenic and reproductive risks and should generally be avoided in pregnancy and used with stringent caution in people who can become pregnant. Antipsychotics such as quetiapine, risperidone, olanzapine, aripiprazole, or others have different metabolic, sedative, movement, and prolactin profiles. Short-term benzodiazepines can be adjuncts for severe agitation or insomnia but are not maintenance mood stabilizers.

ECT is an effective option for severe mania when pharmacotherapy is ineffective, not tolerated, previously responsive, or when a rapid response is clinically necessary. After acute stabilization, transition to a maintenance plan that prevents both mania and depression, address substance use and sleep, and educate the patient and supports about early warning signs. Maintenance selection should consider what worked acutely but also long-term adverse effects and the polarity of previous episodes.

Epidemiology / Risk Factors

• Bipolar I disorder is defined by at least one manic episode and often includes recurrent depressive episodes.
• Onset commonly occurs in adolescence or early adulthood, but secondary mania can present later in life.
• Substance use disorders, anxiety, ADHD, and metabolic disease commonly coexist and complicate management.
• Suicide risk is elevated across bipolar illness, particularly during mixed or depressive states and transitions in care.

Investigations

Baseline Monitoring

Pharmacology

Prognosis / Complications

• Most acute manic episodes improve with effective treatment, but relapse is common without maintenance therapy.
• Repeated episodes can disrupt employment, relationships, finances, and physical health even when each episode eventually remits.
• Adherence, sleep regularity, substance-use treatment, and early recognition of prodromal symptoms improve long-term stability.
• Lithium and other effective maintenance regimens reduce recurrence when tolerated and monitored appropriately.

Patient Education / Counseling

• Explain that mania can impair judgment even when the patient feels unusually productive or well.
• Protect sleep and avoid stimulants, nonprescribed substances, and alcohol during recovery.
• Family or trusted supports can help identify early warning signs such as reduced sleep, accelerated speech, spending, or unusual confidence.
• Do not stop lithium or other maintenance medication abruptly without a treatment plan because relapse can follow discontinuation.
• Discuss pregnancy planning before conception because several mood stabilizers have important fetal risks and medication changes are safest when planned.

Notes

Acute mania treatment has two parallel goals: controlling the current dangerous syndrome and choosing a regimen that can transition into maintenance. A highly sedating antipsychotic may be useful for several nights of severe agitation but may not be the best long-term option for a patient with obesity and diabetes. Reassessment after stabilization is therefore essential.

Antidepressants deserve special attention. If a patient taking an antidepressant develops mania, the antidepressant is generally stopped while antimanic therapy begins. That clinical history also strengthens the need to reassess the original diagnosis of unipolar depression.

The 2023 VA/DoD bipolar guideline includes a dedicated module for mania and hypomania and specifically recognizes ECT for patients with medication resistance, prior positive ECT response, or intolerable medication adverse effects. ECT should therefore be presented as a legitimate evidence-based treatment rather than a historical last resort.

References

1. VA/DoD Clinical Practice Guideline for the Management of Bipolar Disorder (2023) — Link
2. VA/DoD Bipolar Disorder Pocket Card — Link
3. APA Clinical Practice Guideline Resources — Link